论文部分内容阅读
目的探讨低分子肝素钠在慢性阻塞性肺疾病急性加重期(AECOPD)患者中的应用。方法 66例AECOPD患者随机分为研究组与对照组。两组患者均予常规治疗,研究组患者加用低分子肝素钠5000 U皮下注射,每12小时1次,治疗10 d后复测患者动脉血气分析和肺功能。结果治疗后,研究组患者的动脉血气指标、肺功能明显优于对照组患者,差异有统计学意义(P<0.05)。结论 AECOPD患者经低分子肝素钠治疗的临床效果十分显著。
Objective To investigate the application of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods 66 patients with AECOPD were randomly divided into study group and control group. Both groups were treated routinely. Patients in the study group were injected subcutaneously with low molecular weight heparin 5000 U once every 12 hours, and the arterial blood gas analysis and pulmonary function were retested 10 days after treatment. Results After treatment, the arterial blood gas index and pulmonary function of the study group were significantly better than those of the control group (P <0.05). Conclusion AECOPD patients treated with low molecular weight heparin clinical effect is very significant.